Abstract: Many pharmaceutical agents include piperazines or oxopiperazines as part of their core structures. The presence of substituents on these heterocycles has a significant influence on the biological activity, thus the search for efficient routes to control the substitution at different ring positions might have a crucial impact, especially to promote the use of such scaffolds in SAR studies. Many research groups have been engaged in the stereoselective synthesis of polysubstituted piperazines and oxopiperazines and in the majority of cases the stereochemistry of the final compounds is dependent on the starting material configuration. In the present minireview we have summarized some of the most significant approaches towards the stereoselective synthesis and functionalization of substituted piperazines and oxopiperazines, with a particular focus on our own contributions mainly based on readily available natural amino-acids as "chiral pool" starting materials. An efficient and scalable route to orthogonally protected 2-oxopiperazines has been developed using the corresponding diamines as key intermediates: diastereoselective elaboration of the resulting heterocycles was possible by metalation and reaction with electrophiles, leading to anti 3,5-disubstituted-oxopiperazines, in agreement with the model for a conventional 1,3-asymmetric induction. Both piperazines and tetrahydropyrazines could be prepared via LiAlH 4 -mediated reduction of 2-oxopiperazines, depending on reaction conditions. Finally, the diastereoselective synthesis of cyclopropane-containing analogs 2,5-diaza-bicyclo[4.1.0]heptanes was demonstrated by application of the classic Simmons-Smith reaction on enantiomerically enriched dihydro-2H-pyrazines.
INTRODUCTION
Chemical diversity of biologically active compounds has a great importance in medicinal chemistry, particularly when looking for new drug candidates with optimized pharmacological and phamacokinetic properties. Many pharmaceutical agents include a piperazines in their core structures [1, 2] and that is the reason why this heterocycle is considered a "privileged" scaffold [3, 4] for drug discovery and lead optimization. Examples of this kind of pharmacologically important molecules are present among the quinolone antibiotics, [5] HIV-protease inhibitors, [6] 5HT-anxiolytics, [7] antihypertensives, [8] and and -opioid receptor agonists [9] [10] [11] (Fig 1) . Likewise, oxopiperazines, besides of being useful precursors for piperazines, are also present in a range of bioactive compounds including, for instance, constrained substance P analogues, [12] farnesyltransferase (FPTase), geranylgeranyltransferase-I(GGPTase-I), [13] [14] [15] elastase [16] and factor Xa inhibitors, [17] melanocortin receptors (MCR) agonists [18, 19] and fibrinogen glycoprotein IIb-IIIa antagonists [20] (Fig 1) . Consequently, although this class of compounds plays a very important role as central nervous system (CNS) active drugs, they might be potentially *Address correspondence to these authors at the CNR -Istituto di Chimica dei Composti Organometallici (CNR-ICCOM), Via Madonna del Piano 10, 50019 Sesto Fiorentino, Italy; Tel: +39 055 4573555; Fax: +39 055 4573571, E-mails: alessandro.mordini@unifi.it and gianna.reginato@iccom.cnr.it employed as anti-cancer chemotherapeutic agents, [13, 14, [21] [22] [23] [24] [25] [26] or for the treatment and prevention of a range of disorders like arthritis, asthma, depression, [12] obesity, sexual disfunctions, [19] emphysema, cystic fibrosis and rheumatoid arthritis. [16] .
The substituted chiral 2-oxopiperazine core is present in the structure of numerous natural products like polycyclic Pseudotheonamides, [27] Agelastatin A [28] and Marcfortine B, [29] [30] [31] Guadinomine [32] [33] [34] and Piperazirum [35] (Fig.  1) .
In many cases such compounds have shown important biological activity, thus their limited availability, in some cases coupled with the need of proving the molecular structure, has led to sustained interest in their preparation and some elegant enantioselective synthetic routes have been reported. [21, [23] [24] [25] [26] 36] 2-Oxopiperazines play a crucial role in peptidomimetic chemistry, as they are generally used to impart a conformational constraint in peptides by linking the N i and N i-1 positions of the peptide backbone fragment with an ethylene bridge. Due to the increase of structural rigidity, the biological properties of the original peptide are modified, occasionally enhancing affinity, specificity and enzymatic stability. [13, 19, 20, 37, 38] Consequently, piperazines and oxopiperazines have been often used to impart the desired pharmacological and pharmacokinetic properties to a compound, but find a wide application also as bifunctional linking agents to join two components of an analog through a six-membered heterocycle. [4] Finally chiral piperazines have have been exploited as chiral catalysts for enantioselective transformations. [39, 40] Clearly the presence and nature of substituents on the C2, C3, C5 and C6 positions of the ring has a significant influence on the biological activity of these molecules as found, for instance, in the case of 3-substituted piperazines, which have been shown to interact with a variety of receptors in the central nervous system. [41] Of course, the configuration of the asymmetric carbon atoms possibly present in the piperazine template is also very important; this is well illustrated by the example of Praziquantel, a well-known effective antihelminthic drug used worldwide in the treatment of schistosomiasis. The (S)-(+)-enantiomer is inactive and harmless, while the (R)-( )enantiomer is the only one active against the disease (Fig 1) . [42] Although procedures for the synthesis of piperazine derivatives have been known for almost a century, the stereoselective preparation of such scaffolds still remain challenging to organic chemists. Therefore, the search for efficient routes to control the substitution at different ring positions is of crucial importance, especially to promote the use of such scaffolds in SAR studies which have been, so far, mostly limited to the substitution to the two nitrogen atoms.
Many research groups have been engaged in the stereoselective synthesis of polysubstituted piperazines [4, [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] and oxopiperazines [52, [54] [55] [56] [57] [58] [59] [60] and in the majority of cases, in the absence of an asymmetric synthetic strategy, the stereochemistry of the final compounds is dependent on starting material configuration. Readily available, naturally occurring amino-acids have been often used as the source of chirality for starting materials ("chiral pool" approach).
An efficient four-step synthetic strategy to supply a straightforward access to cis-2,5-disubstituted chiral piperazines has been reported by Panda's group using NTosyl (N-Ts) amino-acid-derived aziridines. This protocol has been used to construct the piperazine core framework of natural product (+)-Piperazinomycin.
Alternatively, the copper acetate-mediated regioselective ring opening and ring closing of N-Ts aziridines 1 or intermolecular palladium acetate mediated C-N bond formation using chiral halogenated N-Ts amino derivatives 7 can be used. [62] (Scheme 2). Chiral amino alcohols 6, derived from naturally occurring amino acids, are common intermediates. Both routes are effective; the Pd-catalyzed process is more favourable than the Cu-catalyzed one, which furnished both symmetrical as well as unsymmetrical cis-2,5-disubstituted chiral piperazines 8.
A robust and general solid phase synthesis (SPS) approach to orthogonally N,N -diprotected enantiopure 2,5-disubstituted piperazines has been reported by Franzyk and co-workers. [63] N-nosylaziridine-2-methanol 9 was loaded onto a polystyrene trityl bromide (PS-TrtBr) resin and subjected to microwave-assisted ring-opening with chiral amino alcohol 11. The piperazine scaffold 14 was then obtained using the intramolecular Fukuyama-Mitsunobu reaction, followed by cleaveage (Scheme 3). The strategy allows for easy on-resin protecting group manipulations affording scaffolds with alternative protection patterns. Moreover, additional versatility of the methodology is offered by optional post-cleavage oxidations of the hydroxymethyl group of the 2,5-disubstituted piperazine.
Our research group has been for long time interested in the use of amino acids as building blocks for organic synthesis, and following this approach we have been able to develop new synthetic methodologies to prepare biologically active chiral heterocycles. [64] [65] [66] [67] Taking advantage of such experience we have been also interested to design an efficient and scalable route to enantiomerically enriched 2-oxopiperazines, and piperazines. In our approach the substitution and the stereochemistry at the substituted carbon atom could be dictated by the choice of the starting amino acid and the two nitrogens of the ring can be orthogonally protected, as this would allow the stepwise arrangement of substituents, should the heterocyclic ring be used as a molecular scaffold. [68] We initiated our studies by considering the synthesis of the oxopiperazine ring. Our synthetic pathway is depicted in Scheme 4, and was based on the preparation of vicinal diamines 17 as key intermediates. -Amino aldehydes 16 can be conveniently prepared from tert-butoxycarbonyl (Boc) protected L-amino acids by lithium aluminium hydride (LiAlH 4 ) reduction of the corresponding Weinreb amides 15, [69, 70] and are frequently used to prepare diamines via reductive amination with a primary amine. [71] Following this approach, we reacted commercially available Boc-protected naturally occurring amino acids to obtain the corresponding amino aldehydes 16 which, after reductive amination with benzylamine, provided orthogonally protected diamines 17. Bromoacetylation of the diamines gave 2-bromoacetamides 18, and in turn 5-substituted 2-oxopiperazines 19 (Scheme 4) via a base-promoted cyclisation.
Using such protocol, three new chiral 5-substituted oxopiperazines 19, resulting from Boc protected L-alanine, L-valine and O-benzyl L-tyrosine, were prepared in moderate overall yields and fully characterized after purification. The integrity of the C-5 stereocenter in the final oxopiperazine was estabilished by 1 H-NMR analysis of the corresponding Mosher amide, prepared by Trifluoroacetic acid (TFA) mediated removal of the Boc group followed by reaction of the resulting free amine with (S)--methoxy--trifluoromethylphenylacetic acid chloride.
In order to obtain more decorated scaffolds we decided to study the metalation of compounds 19. Although protons in 3-position were expected to be quite acidic, enolate formation was possible only using a t-BuLi (2.0 eq.)/hexamethylphosphoramide (HMPA) (4.0 eq.) mixture (Scheme 5). The reactions were performed at 78°C and the incipient enolates were intercepted with allylbromide to provide the corresponding 3-allylated 2-oxopiperazines 20a,b,c in moderate to good yields. The reaction was diastereoselective, and the stereochemistry of the new formed stereogenic centre was deduced by nOe difference NMR spectroscopy. The anti relative configuration between substituents at C-3 and C-5 was estabilished, according with the model for a conventional 1,3 asymmetric induction, in which the N-Boc protecting group plays no role in controlling the facial selectivity.
[72] The absolute (3S,5S)-configuration thus followed from that at the C-5 stereogenic center, in turn corresponding to that of the amino acid used as starting material. A range of different electrophiles was reacted after metalation of piperazine 19a and 3,5-disubstituted derivatives (21) (22) (23) (24) (25) were obtained and fully characterized. Double functionalization of position 3 was also possible. Compounds 20a and 23 were deprotonated under the same conditions and reacted with allylbromide to afford 3,3',5-trisubstituted oxopiperazines 26 and 27, respectively (Scheme 6). Once again compound 27 was recovered as a single diastereisomer, in which an anti relative stereochemistry between the allyl group at C-3 and the methyl at C-5 was deduced by nOe difference NMR spectroscopy.
Very recently an elegant stereoselective route for the synthesis of densely substituted 2-oxopiperazines starting from different naturally occurring amino acids has been reported. [60] The key synthetic steps involve dipeptide aldehyde 28 preparation, Wittig reaction, and iodocyclization of alkene 29 (Scheme 7). The regioselective 6-exo-tet-cyclisation mode provided selectively iodide 30, due to an unfavorable steric interaction between the R'' and Boc groups, which efficiently blocked one of the possible transition states. The relative stereochemistry of the newly generated stereocenter was determined by COSY2D-NMR analysis of the derivative which derived from the dipeptide obtained by coupling phenylalanine and isoleucine. A similar ring-closing strategy, based on a Michael addition rather than a iodocyclization as the final step, was also investigated, but the corresponding oxopiperazine could only be recovered in low yield. An interesting alternative approach to the preparation of the oxopiperazine ring system was recently described by Palmieri and co-workers, [73] employing -nitroacrylates as key building blocks. The synthetic procedure was initiated by an aza-Michael reaction involving the attack of a protected amino acid on the electrophilic double bond of a suitable -nitroacrylate 31; the resulting intermediate was then subjected to a metal-mediated reduction of the nitro group, which triggered the subsequent cyclization to oxopiperazine 32 (Scheme 8). Notably, all the steps proceeded under heterogeneous catalysis, which simplified product isolation and reduced waste generation. In the process two new stereogenic centers are formed, but the products were always obtained as mixture of diasteroisomers: if this drawback is addressed, such procedure could constitute a useful approach to the diastereoselective synthesis of libraries of oxopiperazines.
t-BuLi
Oxopiperazines can be used as substrates to prepare the corresponding piperazines after reduction. [43, 74] We have studied the reduction of chiral oxopiperazines 19 and shown that they can be selectively transformed into the corresponding enantiomerically enriched piperazines 33a-d without affecting their stereochemical integrity. However, depending on the reaction conditions, dihydro-2H-pyrazines 34a-d could be selectively obtained as well (Scheme 9) [75] . LiAlH 4 is the most frequently used reagent for reduction of lactams [76] and, although other milder reduction methods exist that make use of weaker reducing agents, it turned out to be the most efficient in this particular case. Indeed, we were pleased to observe that the reaction outcome could be easily adjusted by a careful choice of the reaction conditions: when the reducing agent was used in large excess (5.0 eq.) at room temperature, piperazines 33 were provided, while when a stoichiometric ratio of LiAlH 4 was used at low temperature, dihydro-2H-pyrazines 34 were selectively obtained. These latter compounds were previously unreported and are useful building blocks which can be involved in the synthesis of more decorated piperazine cores or important therapeutic agents.
Very recently the synthesis of non-symmetrical unsubstituted tetrahydropyrazines 37 has been reported [77] via the chemoselective reaction of orthogonally protected diamines 35 with trimethylsilyl ethynyl-1,2-benziodoxol-3(1H)-one (TMS-EBX) 36 used as alkynylating agent (Scheme 10, top) . Such procedure takes advantage of the selectivity of the reagent employed towards N-sulfonylamides versus amides and carbamates, and, although no example on chiral substrates has yet been reported, it represents an alternative approach for the preparation of these interesting intermediates. The reaction was proposed to proceed by attack of the deprotonated sulfonamide on the hypervalent iodine reagent, with formation of an intermediate carbene species; 1,2-shift of the latter to form an alkyne and subsequent attack of the second deprotonated nitrogen atom would provide the cyclic product. To test this hypothesis, N-Ts-N-Boc-ethylenediamine 38 was reacted with Ph-EBX 39 in the presence of NaH: regioselective formation of compound 40, with the phenyl substituent next to the N-Boc group, supported the suggested mechanism (Scheme 10, bottom). Finally, reduction of unsubstituted tetrahydropyrazines to piperazines could be easily accomplished by Pd-catalyzed hydrogenation. Unfortunately, our LiAlH 4 -mediated reduction of oxopiperazines [75] was not successful when 3,5-disubstituted substrates were used, since the requested reaction conditions were too harsh and only decomposition products were observed. Indeed, there are few asymmetric routes to N,N-disubstituted-2,6-dialkylpiperazines, often requiring several steps. [45] [46] [47] Recently the asymmetric syntheses of anti-42 (Scheme 11) or syn-44 (Scheme 12) 2,6-disubstituted piperazines were described, based on Pd-catalyzed hydroamination [78] (Scheme 11) or carboamination [53] of chiral allyldiamines 41 (or 43), respectively, in turn obtained from amino acid precursors.
Thus, while intramolecular hydroamination of aminoalkenes gave excellent yields of the desired piperazines 42 with good to excellent diastereoselectivity in favor of the trans isomer, Pd-catalyzed carboamination with aryl halydes afforded preferentially cis-2,6-disubstituted piperazines 44, although the cyclization proceeded with slightly lower (14:1 to 20:1) diastereoselectivities in this case. As we have already outlined, several structurally tailored versions of piperazines are present in pharmaceutically active compounds. Among others, ring-expanded homopiperazines (diazepines) 45, 2-methyl piperazines 46 or 2,5-diazabicyclo[4.1.0]heptanes 47 are particularly attractive (Fig. 2) as they are minimally modified analogues, not requiring a significant increase of the MW, and thus not in contrast with the well-known empirical medicinal chemistry guidelines such as Lipinski's rules [79, 80] . In particular, the introduction on the scaffold of a fused cyclopropyl group is very interesting as it might establish additional conformational constraints and thus allow to modulate the physical, chemical or pharmacokinetic properties of piperazine-based systems. More specifically, this moiety could mimic a cis 1,2-aminocyclopropane, a structural motif present in a number of biologically active molecules, [81] which is supposed to reduce electron density at the nitrogen atoms of the ring due to inductive effects and perhaps impart a higher metabolic stability because of its inherent bond angle. These concepts have been recently applied in the synthesis of compound 48, an analogue of the antibiotic Ciprofloxacin (Fig. 3) [82] . Obviously, such a problem would be better addressed by developing an asymmetric route to the 2,5-diazabicyclo[4.1.0]heptanes core, as it would be achieved for example by an enantioselective cylopropanation strategy. Indeed there is a lack of systematic studies in cyclopropanation when chiral enamides are used as starting material, [83] and enantiomerically enriched dihydro-2H-pyrazines 34 have been exploited as optimal starting materials for studying such transformation [84] . The conditions used to introduce the cyclopropane moiety in the dihydropyrazine ring, were those employed in the classical Simmons-Smith reaction (Scheme 10). [85, 86] The reaction was found to be stereoselective and compounds 49 were obtained in excellent yields and as a single diastereoisomer after purification. Selected NMR experiments allowed to univocally identify the relative configuration of the new stereocenters formed, revealing an anti relationship between the C5-substituent and the cyclopropyl groups. An explanation for the high level of diastereoselectivity we found in such reaction is shown in the model represented in Scheme 13 and is based on the fact that, likewise to 6-alkyltetrahydropyridines, [87] dihydro-2H-pyrazines might prefer to adopt an axial orientation, which promote the reagent addition onto the olefin face opposite to the alkyl group. 
CONCLUSIONS
In conclusion, in the present article we have summarized some of the most significant approaches towards the stereoselective synthesis and functionalization of substituted piperazines and oxopiperazines, with a particular focus on our own contributions. It was shown that an efficient and scalable route to 2-oxopiperazines could be developed using orthogonally protected diamines as key intermediates: diastereoselective elaboration of the resulting heterocycles was possible by exploiting the embedded stereochemical information provided by the enantiopure amino acid starting materials. Alternative synthetic strategies make use of iodocyclization reactions or a conjugate addition/translactamization sequence as ring-closing events, but diastereoselectivity has still to be demonstrated in the latter case. Both piperazines and tetrahydropyrazines could be prepared via LiAlH 4 -mediated reduction of 2-oxopiperazines, depending on reaction conditions, but they could also be accessed through several cyclization strategies, including ring-closing with hypervalent iodine reagents, as well as Pd-catalysed hydroamination and carboamination. Finally, the diastereoselective synthesis of cyclopropane-containing analogs 2,5-diaza-bicyclo[4.1.0]heptanes was demonstrated by application of the classic Simmons-Smith reaction on enantiomerically enriched dihydro-2H-pyrazines.
The diversity of these synthetic approaches shows that the stereoselective preparation of substituted piperazines and oxopiperazines is currently a topic of great interest for the organic and medicinal chemistry community, and due to the great versatility of these heterocyclic units, the emergence of even more selective and general synthetic methodologies is expected in the near future.
